Status | Study |
Not yet recruiting |
Study Name: Search for Restenosis Markers in Lower Limb Arteritis Condition: Restenosis Lower Limb Arteritis Date: 2017-05-02 Interventions: Other: To look for serum microRNA profiles associated with restenosis To look for serum microRNA profile |
Recruiting |
Study Name: Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis Condition: Takayasu Arteritis Date: 2017-03-13 Interventions: Drug: MMF Patients were treate |
Recruiting |
Study Name: Baricitinib in Relapsing Giant Cell Arteritis Condition: Arteritis, Giant Cell Date: 2017-01-17 Interventions: Drug: Baricitinib 4 milligrams oral Baricitinib daily for 52 weeks |
Recruiting |
Study Name: Clinical Transcriptomics in Systemic Vasculitis (CUTIS) Condition: Cryoglobulinemic Vasculitis (CV) Drug-induced Vasculitis E Date: 2016-12-20 |
Not yet recruiting |
Study Name: Polymyalgia Rheumatica and Giant Cell Arteritis Condition: Polymyalgia Rheumatica Giant Cell Arteritis Date: 2016-12-01 Interventions: Other: 18F-FDG PET/CT 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography |
Not yet recruiting |
Study Name: Takayasu Arteritis Clinical Trial in China Condition: Takayasu Arteritis Date: 2016-11-22 Interventions: Drug: Leflunomide 10mg Tab 20m |
Recruiting |
Study Name: VCRC Tissue Repository Condition: Aortitis Cutaneous Vasculitis Eosinophilic Granulomatosis Date: 2016-11-11 |
Recruiting |
Study Name: Ustekinumab for the Treatment of Giant Cell Arteritis Condition: Giant Cell Arteritis Temporal Arteritis Date: 2016-10-31 Interventions: Drug: Ustekinumab Ustekinumab |
Recruiting |
Study Name: A Randomized Multicenter Study for Isolated Skin Vasculitis Condition: Primary Cutaneous Vasculitis Cutaneous Polyarteritis Nodosa Date: 2016-10-18 Interventions: Drug: Colchicine Randomized to |
Recruiting |
Study Name: Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE Condition: Polymyalgia Rheumatica Date: 2016-09-16 Interventions: Drug: Tocilizumab 6 Intravenou |